COVID-19 and liver disease: mechanistic and clinical perspectives
Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
[HTML][HTML] Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study
Background & Aims Chronic liver disease (CLD) and cirrhosis are associated with immune
dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes …
dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes …
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
HM Dabbous, S Abd-Elsalam, MH El-Sayed… - Archives of …, 2021 - Springer
No specific antiviral drugs have been approved for the treatment of COVID-19. This study
aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter …
aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter …
[HTML][HTML] Hydroxychloroquine in the treatment of COVID-19: a multicenter randomized controlled study
S Abd-Elsalam, ES Esmail, M Khalaf… - The American journal …, 2020 - ncbi.nlm.nih.gov
The COVID-19 pandemic is showing an exponential growth, mandating an urgent need to
develop an effective treatment. Indeed, to date, a well-established therapy is still lacking. We …
develop an effective treatment. Indeed, to date, a well-established therapy is still lacking. We …
[HTML][HTML] Peer Reviewed: COVID-19 Severity and Mortality Among Chronic Liver Disease Patients: A Systematic Review and Meta-Analysis
R Nagarajan, Y Krishnamoorthy, S Rajaa… - Preventing Chronic …, 2022 - ncbi.nlm.nih.gov
Methods We searched for studies reporting COVID-19 outcomes among CLD and non-CLD
patients in databases including Medline, EMBASE, ScienceDirect, Google Scholar, and …
patients in databases including Medline, EMBASE, ScienceDirect, Google Scholar, and …
American association for the study of liver diseases expert panel consensus statement: vaccines to prevent coronavirus disease 2019 infection in patients with liver …
The aim of this document is to provide a concise scientific review of the currently available
COVID‐19 vaccines and those in development, including mRNA, adenoviral vectors, and …
COVID‐19 vaccines and those in development, including mRNA, adenoviral vectors, and …
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
T Marjot, CS Eberhardt, T Boettler, LS Belli… - Journal of …, 2022 - Elsevier
The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …
particularly healthcare professionals and patients. While the rapid development of safe and …
Do zinc supplements enhance the clinical efficacy of hydroxychloroquine?: a randomized, multicenter trial
No specific treatment for COVID-19 infection is available up till now, and there is a great
urge for effective treatment to reduce morbidity and mortality during this pandemic. We …
urge for effective treatment to reduce morbidity and mortality during this pandemic. We …
COVID 19 and liver: An A–Z literature review
MI Metawea, WI Yousif, I Moheb - Digestive and liver disease, 2021 - Elsevier
The coronavirus pandemic has changed the priorities of the whole medical society. During
the clinical course of COVID-19, it has been observed that hepatic injury occurs in a …
the clinical course of COVID-19, it has been observed that hepatic injury occurs in a …